A first-in-human phase I study of the oral Notch inhibitor LY900009 in patients with advanced cancer.
Shubham Pant
No relevant relationships to disclose
Suzanne Fields Jones
No relevant relationships to disclose
Carla Kurkjian
No relevant relationships to disclose
Jeffrey R. Infante
No relevant relationships to disclose
Kathleen N. Moore
No relevant relationships to disclose
Howard A. Burris
No relevant relationships to disclose
D. Scott McMeekin
No relevant relationships to disclose
Jonathan D. Kursar
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
Maciej Zamek-Gliszczynski
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
Emma Jones
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
Eunice Yuen
Employment or Leadership Position - Lilly
Edward Michael Chan
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
Johanna C. Bendell
No relevant relationships to disclose